SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-22-250128
Filing Date
2022-09-23
Accepted
2022-09-23 16:05:03
Documents
12
Period of Report
2022-09-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d396162d8ka.htm   iXBRL 8-K/A 34864
  Complete submission text file 0001193125-22-250128.txt   161234

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ctlt-20220919.xsd EX-101.SCH 2513
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctlt-20220919_lab.xml EX-101.LAB 18031
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctlt-20220919_pre.xml EX-101.PRE 11311
6 EXTRACTED XBRL INSTANCE DOCUMENT d396162d8ka_htm.xml XML 4615
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 001-36587 | Film No.: 221262345
SIC: 2834 Pharmaceutical Preparations